Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India

被引:0
|
作者
Saumya Srivastava
Jyotsna Mishra
Anil Kumar Gupta
Amit Singh
Prem Shankar
Sarman Singh
机构
[1] All India Institute of Medical Sciences,Division of Clinical Microbiology and Molecular Medicine, Department of Laboratory Medicine
来源
Parasites & Vectors | / 10卷
关键词
Visceral leishmaniasis; Miltefosine; Drug resistance; Bihar; Jharkhand;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Relapse of visceral leishmaniasis in an HIV-infected patient successfully treated with a combination of miltefosine and amphotericin B
    McQuarrie, Shauna
    Kasper, Ken
    Moffatt, Dana C.
    Marko, Daniel
    Keynan, Yoav
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2015, 26 (06) : 325 - 329
  • [42] Short Report: Relapse of Visceral Leishmaniasis after Miltefosine Treatment in a Nepalese Patient
    Pandey, Basu Dev
    Pandey, Kishor
    Kaneko, Osamu
    Yanagi, Tetsuo
    Hirayama, Kenji
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 80 (04) : 580 - 582
  • [43] CpG Oligodeoxynucleotide 2006 and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis
    Gupta, Suman
    Sane, Shraddha A.
    Shakya, Nishi
    Vishwakarma, Preeti
    Haq, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (07) : 3461 - 3464
  • [44] Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
    Fabio dos Santos Nogueira
    Valdir Carlos Avino
    Fredy Galvis-Ovallos
    Vera Lucia Pereira-Chioccola
    Marcio Antonio Batistella Moreira
    Ana Paula Peres Lopes Romariz
    Leticia M. Molla
    Ingrid Menz
    Parasites & Vectors, 12
  • [45] Immunomodulatory effect of picroliv on the efficacy of paromomycin and miltefosine in combination in experimental visceral leishmaniasis
    Sane, Shraddha A.
    Shakya, Nishi
    Gupta, Suman
    EXPERIMENTAL PARASITOLOGY, 2011, 127 (02) : 376 - 381
  • [46] Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India
    Thakur, CP
    Dedet, JP
    Narain, S
    Pratlong, F
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2001, 95 (02) : 187 - +
  • [47] Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India
    Das, Pradeep
    Samuels, Steven
    Desjeux, Philippe
    Mittal, Atul
    Topno, Roshan
    Siddiqui, Niyamat Ali
    Sur, Dipika
    Pandey, Arvind
    Sarnoff, Rhonda
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 : 4 - 11
  • [48] Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence
    Sundar, Shyam
    Singh, Om Prakash
    Chakravarty, Jaya
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (11) : 805 - 812
  • [49] Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India
    Meheus, Filip
    Boelaert, Marleen
    Baltussen, Rob
    Sundar, Shyam
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2006, 11 (11) : 1715 - 1724
  • [50] Visceral leishmaniasis (kata-azar) - the Bihar (India) perspective
    Sinha, P. K.
    Ranjan, A.
    Singh, V. P.
    Das, V. N. R.
    Pandey, K.
    Kumar, N.
    Verma, N.
    Lal, C. S.
    Sur, D.
    Manna, B.
    Bhattacharya, S. K.
    JOURNAL OF INFECTION, 2006, 53 (01) : 60 - 64